239 related articles for article (PubMed ID: 19907908)
1. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
Vogel R
ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
[TBL] [Abstract][Full Text] [Related]
2. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
3. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
4. A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline.
Taylor K; Casalegno C; Stengel W
ALTEX; 2011; 28(2):131-48. PubMed ID: 21625829
[TBL] [Abstract][Full Text] [Related]
5. The 7th Amendment to the Cosmetics Directive.
Ruet Rossignol M
Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
[No Abstract] [Full Text] [Related]
6. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
7. Applications of reconstructed skin models in pharmaco-toxicological trials.
Damour O; Augustin C; Black AF
Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
[TBL] [Abstract][Full Text] [Related]
8. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
Indans I
Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
[TBL] [Abstract][Full Text] [Related]
9. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
10. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
[TBL] [Abstract][Full Text] [Related]
11. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
12. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats.
Bulgheroni A; Kinsner-Ovaskainen A; Hoffmann S; Hartung T; Prieto P
Regul Toxicol Pharmacol; 2009 Feb; 53(1):16-9. PubMed ID: 18977273
[TBL] [Abstract][Full Text] [Related]
13. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
[TBL] [Abstract][Full Text] [Related]
14. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
15. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
Hartung T; Blaauboer BJ; Bosgra S; Carney E; Coenen J; Conolly RB; Corsini E; Green S; Faustman EM; Gaspari A; Hayashi M; Wallace Hayes A; Hengstler JG; Knudsen LE; Knudsen TB; McKim JM; Pfaller W; Roggen EL
ALTEX; 2011; 28(3):183-209. PubMed ID: 21993956
[TBL] [Abstract][Full Text] [Related]
16. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
Almeida A; Sarmento B; Rodrigues F
Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
[TBL] [Abstract][Full Text] [Related]
17. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
[TBL] [Abstract][Full Text] [Related]
18. Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019.
Gustafson E; Debruyne C; De Troyer O; Rogiers V; Vinken M; Vanhaecke T
Arch Toxicol; 2020 Nov; 94(11):3723-3735. PubMed ID: 32839844
[TBL] [Abstract][Full Text] [Related]
19. A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010.
Balls M; Clothier R
Altern Lab Anim; 2010 Oct; 38(5):345-53. PubMed ID: 21105753
[TBL] [Abstract][Full Text] [Related]
20. Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation.
Rovida C; Basketter D; Casati S; de Silva O; Hermans H; Kimber I; Manou I; Weltzien HU; Roggen E
Altern Lab Anim; 2007 Jun; 35(3):317-22. PubMed ID: 17650950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
